Aquablation水刀消融治疗4年随访结果:最大单中心研究的真实世界数据及相关结局随访
本前瞻性单中心观察性研究纳入2019年12月至2023年12月期间接受机器人辅助Aquablation治疗的中重度良性前列腺增生(BPH)男性患者330例,评估4年安全性和疗效。结果显示IPSS从基线23.8降至4年时6.9,Qmax从6.4 mL/秒增至17.4 mL/秒,1年时前列腺体积平均缩小45.5 mL(-41.3%),顺行射精保留率249/250(99.6)%。作者结论认为Aquablation对BPH患者安全且4年疗效持久。
要点
- 330例中重度BPH患者接受Aquablation,4年IPSS从23.8降至6.9,Qmax从6.4 mL/秒增至17.4 mL/秒。
- 1年时前列腺体积平均缩小45.5 mL(-41.3%);顺行射精保留249/250(99.6)%。
- 术后1个月内尿路感染37例(11.2%),需输血出血11例(3.3%),二次手术13例(3.9%)。
核心结论
- 作者认为Aquablation对BPH男性不仅安全,且4年疗效持久。
研究设计与样本
- 前瞻性单中心观察性研究,评估机器人辅助Aquablation治疗中重度BPH的结局。
- 研究时间为2019年12月至2023年12月,共纳入330例男性患者。
- 在3个月、6个月及第1至4年评估年龄、前列腺体积、IPSS评分、Qmax和PVR等患者级数据。
- 主要结局包括IPSS评分变化、Qmax变化、PVR变化、顺行射精保留及并发症。
主要发现
- 基线平均前列腺体积为110.3 mL(范围38-330 mL)。
- IPSS从基线23.8(SD 8.4)改善至4年时6.9(SD 2.9)。
- 平均Qmax从基线6.4 mL/秒(SD 4.2)增至4年时17.4 mL/秒(SD 5.5)。
- 1年时平均前列腺体积缩小45.5 mL(-41.3%)。
- 术后顺行射精保留于249/250例(99.6)%的男性。
关键数值与推荐
- 并发症包括术后第1个月内尿路感染37例(11.2%)和需输血的出血11例(3.3%)。
- 13例患者(3.9%)需二次手术,其中2例因术后出血、1例因膀胱颈破裂、10例(3.0%)因经尿道切除残余前部组织。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report real-world experience of 4-year safety and efficacy outcomes of Aquablation procedure for the treatment of men with symptomatic benign prostatic hyperplasia (BPH). METHODS: This is a prospective single-center, observational study evaluating the outcomes of robotic-assisted Aquablation therapy for moderate-to-severe BPH between December 2019 and December 2023. Patient-level data included age, prostate volume, IPSS score, peak urinary flow rate (Qmax), post-void residual (PVR) were evaluated at 3 M, 6 M, and Years 1-4. Primary outcomes included change in IPSS score, change in Qmax, change in PVR, preservation of antegrade ejaculation, and complications. RESULTS: In this cohort of 330 men, mean prostatic volume was 110.3 mL (range 38-330 mL) at baseline. International Prostate Symptom Score (IPSS) improved from a baseline of 23.8 (SD 8.4) to 6.9 (SD 2.9) at 4 years. Mean peak urinary flow rate (Qmax) also demonstrated improvement and increased from 6.4 mL/sec (SD 4.2) to 17.4 mL/sec (SD 5.5) at 4 years. At 1 year, mean prostate volume reduction was 45.5 mL (-41.3%). Postoperative antegrade ejaculation was preserved in 249/250 men (99.6)% of men. Complications included urinary tract infection within first month after procedure in 37 (11.2%) and bleeding requiring blood transfusion in 11 (3.3%). Thirteen patients (3.9%) required a second procedure including 2 for post-operative bleeding, 1 for a bladder neck disruption and 10 (3.0%) for transurethral resection of residual anterior tissue. CONCLUSION: We demonstrate Aquablation to not only be safe but also providing durable outcomes at 4 years for men with BPH.
引用
- Omidele OO, Siegal AS, Roshandel R, et al. Aquablation at 4-years: Real World Data From the Largest Single-center Study With Associated Outcomes Follow-up. Urology. 2024. PMID: 39084348. doi:10.1016/j.urology.2024.07.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。